TBG Diagnostics Stock Forecast for 2023 - 2025 - 2030
Updated on 04/27/2024
Stock Rating
0
Price Target
0.00
Consensus
-
Upside
0.00%
Analysts
0
Stock Rating
0
Upside
0.00%
Analysts
0
Price Target
0.00
TBG Diagnostics Stock Forecast and Price Target
In recent months, notable analysts have provided yearlong price targets for TBG Diagnostics, with the average target coming in at 0.00. If it were to be achieved, this would result in a potential upside of approximately 100 percent from the most recent closing price in May, 2021. The high end is 0.00, and the low is 0.00. Although you may not be interested in TDL stock, you should still be aware of its competitors.
0.00
0.00% Upside
-
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| GSS Stock Forecast | Genetic Signatures | Buy |
11
|
$0.69 | Buy/Sell | $1.19 | 8.70% |
| ADO Stock Forecast | AnteoTech | - |
6
|
$0.02 | Buy/Sell | $0.38 | -100.00% |
| UBI Stock Forecast | Universal Biosensors | - |
0
|
$0.15 | Buy/Sell | $0.38 | -100.00% |
| RHY Stock Forecast | Rhythm Biosciences | - |
6
|
$0.08 | Buy/Sell | $0.00 | -100.00% |
| APL Stock Forecast | Associate Global Partners | - |
0
|
$0.17 | Buy/Sell | $0.00 | -100.00% |
.jpg)
.jpg)